NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MythA.00184.a: 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (A0QR00 homolog)

Target Characteristics

from organism: Mycobacterium thermoresistibile ATCC 19527 / NCTC 10409
most recent status: soluble
center reference id: MythA.00184.a
is community request: False
associated disease: Respiratory Infection
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MythA.00184.a.A1.GE28711 Full length( MythA.00184.a ) 1 363 GE28711
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

External Resources

Resource Reference ID
PATRIC ID: fig|1078020.3.peg.3027
RefSeq: WP_003926560.1
UniProt: G7CHI6

Enzyme & Pathway Information

Pathway Pathway ID EC Number
5.4.2.1
homolactic fermentation ANAEROFRUCAT-PWY 5.4.2.11
glycolysis III (from glucose) ANAGLYCOLYSIS-PWY 5.4.2.11
glycolysis I (from glucose 6-phosphate) GLYCOLYSIS 5.4.2.11
superpathway of glycolysis and the Entner-Doudoroff pathway GLYCOLYSIS-E-D 5.4.2.11
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass GLYCOLYSIS-TCA-GLYOX-BYPASS 5.4.2.11
superpathway of hexitol degradation (bacteria) HEXITOLDEGSUPER-PWY 5.4.2.11
heterolactic fermentation P122-PWY 5.4.2.11
superpathway of N-acetylneuraminate degradation P441-PWY 5.4.2.11
hexitol fermentation to lactate, formate, ethanol and acetate P461-PWY 5.4.2.11
formaldehyde assimilation I (serine pathway) PWY-1622 5.4.2.11
glycolysis II (from fructose 6-phosphate) PWY-5484 5.4.2.11
gluconeogenesis III PWY66-399 5.4.2.11
glycolysis VI (metazoan) PWY66-400 5.4.2.11
superpathway of anaerobic sucrose degradation PWY-7345 5.4.2.11

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MAAAGVWRVI RMCRGGGDRP DVAPWAHVRR DHRTFTAAIA RSPQPSHTHR SDRTADMRPG PHEMISAMGN GATLILLRHG ESDWNAKNLF TGWVDVDLTD KGRAEAVRAG ELMAELDRLP DVVYTSLLRR AITTANLALD RADRHWIPVH RSWRLNERHY GALQGLNKAE TKEKYGEEQF MAWRRSYDTP PPPIERGSTY SQDGDPRYAD IDGGPLTECL ADVVARFVPY YEQTIVPDLR AGKTVLIAAH GNSLRALVKY LDGMSDEEVV GLNIPTGIPL RYDLDENLKP KVVGGQYLXX XXXXXXXXXX XXXXXXXXXX XXGPGLGEQR VNSGRISQLT GVTCPVSAAR SWDDVHPLRT IFA

NT Sequence
GTGGCCGCGG CGGGCGTGTG GCGGGTGATT CGAATGTGCC GTGGTGGTGG CGATCGGCCC GATGTCGCAC CGTGGGCGCA CGTTCGCCGT GACCATCGCA CGTTCACCGC AGCCATCGCA CGTTCACCGC AGCCATCGCA CACTCACCGC AGTGACCGCA CGGCGGACAT GCGACCCGGG CCACATGAGA TGATTTCGGC CATGGGAAAC GGTGCCACGC TGATTCTGCT CCGCCACGGT GAGAGTGACT GGAACGCCAA GAACCTGTTC ACCGGCTGGG TCGACGTCGA CCTCACCGAC AAGGGCCGCG CCGAAGCGGT GCGTGCCGGG GAGTTGATGG CCGAGCTCGA CCGGCTGCCC GACGTGGTCT ACACCTCGCT GCTGCGCCGC GCCATCACCA CCGCCAACCT GGCGCTGGAC CGGGCGGACC GGCACTGGAT CCCCGTCCAC CGCAGCTGGC GGCTCAACGA ACGCCACTAC GGCGCGCTGC AGGGGCTGAA CAAGGCCGAG ACCAAGGAGA AATACGGCGA AGAGCAGTTC ATGGCCTGGC GGCGCAGCTA CGACACCCCG CCCCCACCCA TCGAGCGGGG CAGCACGTAC AGCCAGGACG GCGACCCGCG CTACGCCGAC ATCGACGGCG GTCCGCTGAC CGAATGCCTG GCCGACGTGG TCGCCCGGTT CGTGCCCTAC TACGAGCAGA CCATCGTGCC GGATCTGCGG GCCGGCAAGA CGGTGCTGAT CGCCGCGCAC GGCAACTCGC TGCGGGCGCT GGTGAAGTAC CTCGACGGCA TGTCCGACGA GGAGGTCGTC GGCCTCAACA TCCCGACCGG GATCCCGCTT CGCTACGACC TGGACGAGAA CCTCAAACCG AAGGTCGTCG GCGGGCAGTA TCTGNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNNNNGGGC CCGGCCTGGG CGAACAGCGG GTGAACAGCG GCCGAATTTC TCAGCTCACG GGTGTGACGT GTCCCGTTTC GGCCGCGCGC AGCTGGGATG ACGTTCACCC GTTGCGTACG ATTTTCGCG

© 2020 Seattle Children's Research Institute. All rights reserved.